ReShape Lifesciences Files 2024 10-K
Ticker: HIND · Form: 10-K · Filed: Apr 4, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 10-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, healthcare
TL;DR
ReShape Lifesciences dropped its 2024 10-K. Check financials.
AI Summary
ReShape Lifesciences Inc. filed its 2024 10-K on April 4, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Obalon Therapeutics Inc., is involved in the pharmaceutical preparations industry. The filing details financial information and business operations for the period.
Why It Matters
This 10-K filing provides investors and stakeholders with a comprehensive overview of ReShape Lifesciences' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a company in the pharmaceutical preparations sector, ReShape Lifesciences faces inherent risks related to product development, regulatory approvals, and market competition.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Filer of the 10-K
- Obalon Therapeutics Inc. (company) — Former name of ReShape Lifesciences Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-04-04 (date) — Filing date
FAQ
What is the primary business of ReShape Lifesciences Inc.?
ReShape Lifesciences Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When did ReShape Lifesciences Inc. change its name from Obalon Therapeutics Inc.?
The company changed its name from Obalon Therapeutics Inc. on February 20, 2008.
What is the filing date of this 10-K report?
This 10-K report was filed on April 4, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Where is ReShape Lifesciences Inc. headquartered?
ReShape Lifesciences Inc. is headquartered in San Clemente, California, with its business address at 1001 Calle Amanecer.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 4, 2025 regarding ReShape Lifesciences Inc. (HIND).